• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Fluorescein Angiography Market

    ID: MRFR/HC/27933-HCR
    128 Pages
    Kinjoll Dey
    October 2025

    Fluorescein Angiography Market Research Report By Application (Diabetic Retinopathy, Age-Related Macular Degeneration, Retinal Vein Occlusion, Uveitis, Other Ophthalmic Conditions), By Equipment Type (Fundus Cameras, Spectral-Domain Optical Coherence Tomography, Fluorescein Angiography Cameras, Indocyanine Green Angiography Cameras), By End User (Hospitals and Clinics, Ophthalmic Surgery Centers, Research Institutions), By Fluorescein Type (Sodium Fluorescein, Calcium Fluorescein), By Administration Route (Intravenous, Ocular), By Distributi...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Fluorescein Angiography Market Infographic
    Purchase Options

    Fluorescein Angiography Market Summary

    The global fluorescein angiography market is projected to grow from 1.80 USD billion in 2024 to 2.78 USD billion by 2035, reflecting a steady increase in demand.

    Key Market Trends & Highlights

    Fluorescein Angiography Key Trends and Highlights

    • The market is expected to witness a compound annual growth rate (CAGR) of 4.02 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 2.78 USD billion, indicating robust growth potential.
    • in 2024, the market is valued at 1.80 USD billion, laying a solid foundation for future expansion.
    • Growing adoption of fluorescein angiography due to increasing prevalence of retinal diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 1.80 (USD Billion)
    2035 Market Size 2.78 (USD Billion)
    CAGR (2025-2035) 4.02%

    Major Players

    Novartis AG, Bayer AG, Alcon Laboratories, Inc., Johnson Johnson Vision Care, Inc., Ziemer Ophthalmic Systems AG, Heidelberg Engineering GmbH, Reichert Technologies, Marco Ophthalmic, Inc., EssilorLuxottica, Optovue, Inc., Tomey Corporation, HaagStreit Holding AG, Bausch + Lomb Incorporated, Canon, Inc., Topcon Corporation, Nidek Co., Ltd., Carl Zeiss Meditec AG

    Fluorescein Angiography Market Trends

    The rising prevalence of age-related macular degeneration, diabetic retinopathy, and other retinal disorders is driving the demand for fluorescein angiography. Furthermore, increasing awareness about the importance of regular eye check-ups and early detection of ocular diseases is contributing to the growth of the market.

    Exploring opportunities in emerging markets, where healthcare infrastructure is developing, and expanding the use of fluorescein angiography in non-ophthalmic applications, such as dermatology and oncology, are key growth avenues.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    The increasing prevalence of retinal diseases and advancements in imaging technology are driving the demand for fluorescein angiography, which plays a crucial role in the early diagnosis and management of ocular conditions.

    National Eye Institute, National Institutes of Health

    Fluorescein Angiography Market Drivers

    Market Growth Projections

    The Global Fluorescein Angiography Market Industry is projected to experience steady growth over the next decade. With a compound annual growth rate (CAGR) of 4.02% anticipated from 2025 to 2035, the market is expected to evolve in response to changing healthcare needs and technological advancements. This growth trajectory reflects the increasing demand for effective diagnostic tools in ophthalmology. As the industry adapts to new challenges and opportunities, stakeholders are likely to invest in research and development to enhance the efficacy of fluorescein angiography. The market's expansion is indicative of a broader trend towards improved eye care and patient outcomes.

    Growing Awareness and Education

    There is a notable increase in awareness and education regarding eye health, which is positively impacting the Global Fluorescein Angiography Market Industry. Campaigns aimed at educating the public about the importance of regular eye examinations and early detection of eye diseases are gaining traction. Healthcare professionals are also being trained to utilize fluorescein angiography effectively, ensuring that patients receive timely and accurate diagnoses. This heightened awareness is likely to lead to an increase in patient referrals for fluorescein angiography, thereby driving market growth. As more individuals seek preventive care, the demand for these imaging services is expected to rise.

    Increased Healthcare Expenditure

    The Global Fluorescein Angiography Market Industry is benefiting from rising healthcare expenditure across various regions. Governments and private sectors are investing more in healthcare infrastructure, which includes the acquisition of advanced diagnostic tools like fluorescein angiography systems. This trend is particularly evident in developing nations, where improved access to healthcare services is a priority. As healthcare budgets grow, the demand for effective diagnostic solutions is expected to rise, contributing to the market's growth. By 2035, the market could reach 2.78 USD Billion, reflecting the positive impact of increased investment in healthcare technologies.

    Regulatory Support and Guidelines

    The Global Fluorescein Angiography Market Industry is supported by regulatory frameworks and guidelines that promote the use of advanced imaging techniques. Regulatory bodies are increasingly recognizing the importance of fluorescein angiography in diagnosing and managing eye diseases. This support not only encourages healthcare providers to adopt these technologies but also fosters innovation within the industry. As regulations evolve to accommodate new technologies and methodologies, the market is likely to experience growth. The establishment of standardized protocols for fluorescein angiography could enhance its credibility and acceptance among healthcare professionals, further driving market expansion.

    Rising Prevalence of Eye Diseases

    The Global Fluorescein Angiography Market Industry is experiencing growth due to the increasing prevalence of eye diseases such as diabetic retinopathy and age-related macular degeneration. According to health statistics, the number of individuals diagnosed with these conditions is on the rise, leading to a higher demand for diagnostic imaging techniques. Fluorescein angiography plays a crucial role in the early detection and management of these diseases, which could potentially improve patient outcomes. As the global population ages and the incidence of diabetes increases, the market is projected to reach 1.8 USD Billion in 2024, indicating a strong need for advanced imaging solutions.

    Technological Advancements in Imaging Techniques

    Advancements in imaging technology are significantly influencing the Global Fluorescein Angiography Market Industry. Innovations such as high-resolution imaging and enhanced software for image analysis are improving the accuracy and efficiency of fluorescein angiography procedures. These technological improvements not only facilitate better diagnosis but also enhance patient comfort during the procedure. As healthcare providers adopt these advanced technologies, the market is likely to expand, reflecting a growing trend towards precision medicine. The integration of artificial intelligence in image interpretation may further streamline workflows, potentially leading to an increase in market value as it evolves to meet the demands of modern healthcare.

    Market Segment Insights

    Fluorescein Angiography Market Application Insights

    The Global Fluorescein Angiography Market Segmentation by Application includes Diabetic Retinopathy, Age-Related Macular Degeneration, Retinal Vein Occlusion, Uveitis, and Other Ophthalmic Conditions. Diabetic Retinopathy held the largest market share of over 30.0% in 2023 and is expected to maintain its dominance over the forecast period.

    The high prevalence of diabetes and the increasing geriatric population are major factors driving the growth of this segment. Age-related macular degeneration is another major application segment, accounting for over 25.0% of the Global Fluorescein Angiography Market revenue in 2023.

    The rising incidence of age-related eye diseases, such as macular degeneration, is a key factor contributing to the growth of this segment. Retinal Vein Occlusion, Uveitis, and Other Ophthalmic Conditions collectively accounted for a market share of over 40.0% in 2023.

    The increasing awareness about eye health and the availability of advanced diagnostic techniques are expected to drive the growth of these segments in the coming years. The Global Fluorescein Angiography Market is expected to witness significant growth in the coming years, with a CAGR of over 4.0% during the forecast period.

    Factors such as the rising prevalence of eye diseases, the increasing adoption of advanced diagnostic techniques, and the growing demand for minimally invasive procedures are expected to contribute to the market growth.

    Fluorescein Angiography Market Equipment Type Insights

    The Equipment Type segment of the Global Fluorescein Angiography Market is expected to grow significantly over the forecast period.

    The market growth is driven by the increasing prevalence of eye diseases such as

    , macular degeneration, and glaucoma, which require fluorescein angiography for diagnosis and monitoring.

    Among the different equipment types, Fundus Cameras held the largest market share in 2023 and is expected to maintain its dominance throughout the forecast period. Fundus cameras are widely used for capturing images of the retina, and they offer high-resolution images that aid in the accurate diagnosis of eye diseases.

    Spectral-Domain Optical Coherence Tomography (SD-OCT) is another important equipment type in the Fluorescein Angiography Market, with a growing market share due to its ability to provide cross-sectional images of the retina, which allows for the detailed visualization of retinal structures. Fluorescein Angiography Cameras and Indocyanine Green Angiography Cameras are also significant equipment types in the market, used for capturing images of the retinal vasculature and choroid, respectively.

    Fluorescein Angiography Market End User Insights

    The Global Fluorescein Angiography Market segmentation by end users includes hospitals and clinics, ophthalmic surgery centers, and research institutions. Among these, hospitals and clinics are expected to hold the largest share of the market in 2023, with a revenue of around 0.75 billion USD.

    This is due to the high prevalence of eye diseases and the increasing number of diagnostic procedures performed in hospitals and clinics. Ophthalmic surgery centers are expected to witness significant growth in the coming years, owing to the rising number of eye surgeries being performed and the growing adoption of advanced imaging techniques.

    Research institutions are also expected to contribute to the growth of the market, as they are involved in the development and evaluation of new fluorescein angiography technologies. The growing demand for non-invasive and accurate diagnostic procedures is driving the growth of the Global Fluorescein Angiography Market.

    Fluorescein Angiography Market Fluorescein Type Insights

    The Fluorescein Type segment of the Global Fluorescein Angiography Market is segmented into Sodium Fluorescein and Calcium Fluorescein. Among these, Sodium Fluorescein dominates the market, accounting for a larger share of the Global Fluorescein Angiography Market revenue in 2023.

    The dominance of Sodium Fluorescein can be attributed to its widespread use in various ophthalmic procedures, including angiography and fundus imaging. The Global Fluorescein Angiography Market is expected to witness steady growth over the forecast period, driven by the increasing prevalence of eye diseases and the growing demand for minimally invasive diagnostic procedures.

    Technological advancements and the development of new applications for Fluorescein Angiography are also expected to contribute to the market growth. Calcium Fluorescein, on the other hand, is primarily used in research applications and holds a smaller market share compared to Sodium Fluorescein. Its market growth is anticipated to be influenced by the increasing adoption of advanced imaging techniques in research settings.

    Fluorescein Angiography Market Administration Route Insights

    The Global Fluorescein Angiography Market is segmented based on Administration Route into Intravenous and Ocular. Intravenous administration held the largest market share in 2023 and is expected to maintain its dominance throughout the forecast period.

    The growth of this segment can be attributed to the widespread use of intravenous injections for administering fluorescein dye during angiography procedures. Ocular administration, on the other hand, is expected to experience significant growth over the forecast period due to the increasing adoption of non-invasive techniques for ophthalmic diagnosis.

    Fluorescein Angiography Market Distribution Channel Insights

    Fluorescein angiography, a crucial diagnostic imaging technique in ophthalmology, is widely accessible through multiple distribution channels.

    Direct Sales: Direct sales involve manufacturers selling Fluorescein Angiography devices and consumables directly to healthcare providers, such as hospitals, clinics, and ophthalmology centers. This channel ensures control over product quality, customization, and personalized customer support.

    In 2023, the direct sales segment accounted for approximately 40% of the Global Fluorescein Angiography Market revenue.

    Distributors: Distributors act as intermediaries between manufacturers and healthcare providers. They play a significant role in expanding market reach, ensuring efficient logistics, and providing technical support. The Global Fluorescein Angiography Market segmentation by distribution channel reveals that distributors captured a substantial market share of around 35% in 2023.

    Hospital Supply Stores: Hospital supply stores are dedicated outlets within hospitals that cater to the procurement needs of healthcare professionals. These stores offer a comprehensive range of medical devices, including Fluorescein Angiography equipment and consumables.

    Get more detailed insights about Fluorescein Angiography Market

    Key Companies in the Fluorescein Angiography Market market include

    Future Outlook

    Fluorescein Angiography Market Future Outlook

    The Fluorescein Angiography Market is projected to grow at a 4.02% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of eye diseases, and rising healthcare expenditure.

    New opportunities lie in:

    • Develop AI-driven imaging solutions to enhance diagnostic accuracy.
    • Expand telemedicine services for remote fluorescein angiography consultations.
    • Invest in training programs for healthcare professionals to improve procedure adoption.

    By 2035, the Fluorescein Angiography Market is expected to achieve substantial growth, reflecting advancements and increased demand.

    Market Segmentation

    Fluorescein Angiography Market End User Outlook

    • Hospitals and Clinics
    • Ophthalmic Surgery Centers
    • Research Institutions

    Fluorescein Angiography Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Fluorescein Angiography Market Application Outlook

    • Diabetic Retinopathy
    • Age-Related Macular Degeneration
    • Retinal Vein Occlusion
    • Uveitis
    • Other Ophthalmic Conditions

    Fluorescein Angiography Market Equipment Type Outlook

    • Fundus Cameras
    • Spectral-Domain Optical Coherence Tomography
    • Fluorescein Angiography Cameras
    • Indocyanine Green Angiography Cameras

    Fluorescein Angiography Market Fluorescein Type Outlook

    • Sodium Fluorescein
    • Calcium Fluorescein

    Fluorescein Angiography Market Administration Route Outlook

    • Intravenous
    • Ocular

    Fluorescein Angiography Market Distribution Channel Outlook

    • Direct Sales
    • Distributors
    • Hospital Supply Stores

    Report Scope

    Report Attribute/Metric Details
    Market Size 2024    1.80 (USD Billion)
    Market Size 2025    1.87 (USD Billion)
    Market Size 2035 2.78 (USD Billion)
    Compound Annual Growth Rate (CAGR) 4.02% (2025 - 2035)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2024
    Market Forecast Period 2025 - 2035
    Historical Data 2020 - 2024
    Market Forecast Units USD Billion
    Key Companies Profiled Alcon Laboratories, Inc., Johnson Johnson Vision Care, Inc., Ziemer Ophthalmic Systems AG, Heidelberg Engineering GmbH, Reichert Technologies, Marco Ophthalmic, Inc., EssilorLuxottica, Optovue, Inc., Tomey Corporation, Haag-Streit Holding AG, Bausch + Lomb Incorporated, Canon, Inc., Topcon Corporation, Nidek Co., Ltd., Carl Zeiss Meditec AG
    Segments Covered Application, Equipment Type, End User, Fluorescein Type, Administration Route, Distribution Channel, Regional
    Key Market Opportunities Rising prevalence of diabetic retinopathy, technological advancements, increasing healthcare expenditure, expanding geriatric population, and unmet medical needs.
    Key Market Dynamics Technological advancements, growing geriatric population, rising prevalence of eye diseases, increasing healthcare expenditure, and expanding applications in ophthalmology
    Countries Covered North America, Europe, APAC, South America, MEA

    FAQs

    What is the projected growth of the Fluorescein Angiography market?

    The Fluorescein Angiography market is the expected increase in total market value of 2.78 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the Fluorescein Angiography market?

    Fluorescein Angiography market size was valued at approximately 1.8 billion USD in 2024. This figure will reach 2.78 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the Fluorescein Angiography market?

    Fluorescein Angiography market is expected to grow at a CAGR of 4.02% between 2025 and 2035.

    How much will the Fluorescein Angiography market be worth by 2035?

    Fluorescein Angiography market is expected to be worth of 2.78 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the Fluorescein Angiography market perform over the next 10 years?

    Over the next 10 years the Fluorescein Angiography market is expected to shift from usd billion 1.8 to 2.78 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    Which region is expected to dominate the Global Fluorescein Angiography Market?

    North America is anticipated to dominate the global Fluorescein Angiography Market throughout the forecast period, owing to the presence of a large patient population with ophthalmic disorders and a well-established healthcare infrastructure.

    What are the key factors driving the growth of the Global Fluorescein Angiography Market?

    The rising prevalence of ophthalmic disorders, technological advancements in angiography devices, and increasing awareness about the benefits of fluorescein angiography are the primary factors fueling market growth.

    Which application is expected to hold the largest share of the Global Fluorescein Angiography Market?

    Ophthalmology is anticipated to account for the largest share of the global Fluorescein Angiography Market due to the widespread use of fluorescein angiography in diagnosing and monitoring various retinal diseases.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials